Therapy News and Research

RSS

Children with Down syndrome at greater risk of an associated form of arthritis

A new study finds that children with Down syndrome are at an increased risk of an associated form of arthritis.

10 Nov 2019

Effective non-surgical treatment options for urinary incontinence

A common myth about urinary incontinence (the loss of bladder control or urinary leakage) in women is that surgery is your only option.

10 Nov 2019

Study shows how glucocorticoid hormones control sugar and fat levels over the course of 24 hours

For the first time, a study led by researchers at Helmholtz Zentrum München and the German Center for Diabetes Research shows how glucocorticoid hormones, such as cortisol, control sugar and fat levels differently during day and night, feeding and fasting, rest and activity, over the course of 24 hours.

10 Nov 2019

Preclinical data on new drug combination to treat neuroblastoma published

Neuroblastoma is the most common cancer outside of the brain in infants and young children and often fails to respond to therapy. Though it can appear in several areas of the body, it commonly develops as a solid tumor most frequently found in or adjacent to the adrenal glands, which sit atop the kidneys.

10 Nov 2019

Glutamine-blocking compound slows cancer growth, unleashes anti-tumor immune response

A compound developed by Johns Hopkins researchers that blocks glutamine metabolism can slow tumor growth, alter the tumor microenvironment and promote the production of durable and highly active anti-tumor T cells.

10 Nov 2019

Study finds novel potential approach to treat type 2 diabetes

The protein adipsin, which is produced in body fat, helps protect insulin-secreting cells called pancreatic beta cells from destruction in type 2 diabetes, according to a new study by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

9 Nov 2019

UC researcher finds new treatment option for liver transplant patients

A drug commonly used to treat both asthma and inflammatory bowel disease, budesonide, may also be useful as an anti-organ rejection medication for liver transplant patients leading to fewer serious side effects than the most commonly used therapy, according to a University of Cincinnati researcher.

9 Nov 2019

Researchers identify new factors associated with higher mortality rates in Parkinson's patients

By following a group of newly diagnosed patients with Parkinson's disease for a decade or more, researchers have been able to identify several factors never before reported that appear to be associated with higher mortality rates in PD patients compared to the general population.

8 Nov 2019

Investigators use the power of computation to build better targeted drug therapy

Antibody drug conjugates (ADCs) -- cancer drugs that are designed to target and destroy cancerous tissue while leaving healthy cells intact -- represent a long sought-after advancement in cancer therapy.

8 Nov 2019

Genetic diversity impacts efficacy of cancer immunotherapy

The constant battle against infectious pathogens has had a decisive influence on the human immune system over the course of our evolution.

8 Nov 2019

Combination therapy shows promise for transplanting HCV-infected organs

Data from a new study presented this week at The Liver Meeting – held by the American Association for the Study of Liver Diseases – found that combination therapy with direct-acting antivirals (DAAs) and ezetimibe.

8 Nov 2019

Breakthrough research discovers new way to slow progression of diabetic kidney disease

With World Diabetes Day (14th November) on the horizon new breakthrough research from Monash University has discovered a way to slow the progression of kidney disease in people with diabetes.

8 Nov 2019

Kibow Biotech participates in ASN Kidney Week 2019

Kibow Biotech announces its 15th consecutive year of participation in the ASN Conferences after 22 years as a pioneer in the use of Pro/Prebiotics in people with failing kidneys.

From Kibow Biotech Inc. 8 Nov 2019

Promega and Merck collaborate to develop MSI companion diagnostic for use with anti-PD-1 therapy

Promega Corporation today announced it has entered into a global collaboration with Merck, to develop Promega’s microsatellite instability technology.

From Promega Corporation 8 Nov 2019

Hitachi and CLB in Lyon-France announce research collaboration to fight against cancer with AI

Hitachi, Ltd. and Centre Leon Berard (CLB), a leading French Comprehensive Cancer Center in Lyon-France, announced today that they have entered into an agreement to jointly promote research and development aimed at improving the efficiency of diagnosis and treatment of cancer and established a new research laboratory called Hitachi Lyon Lab on the CLB site, starting November 5th.

8 Nov 2019

New stem cell technology gives new hope for high-risk leukemia patients

Few people get a second chance at life. And fewer still are forced to take it before their 25th birthday. Tyler Rabey is one of those people. He was diagnosed with an aggressive form of leukemia at the prime of his life; a cancer that defied all standard treatments.

8 Nov 2019

First device-based, non-drug therapy for treating ADHD in children

Deciding how to treat attention deficit hyperactivity disorder in children can be a difficult decision for parents. Stimulants, such as Adderall and Ritalin, are the most commonly prescribed ADHD treatments - and are considered to be the most effective.

8 Nov 2019

UK to be transformed into global hub for next-generation radiotherapy research

The UK will be transformed into a global hub for radiotherapy research, pioneering the use of the latest techniques such as FLASH radiotherapy and artificial intelligence, with a new £56 million research network announced by Cancer Research UK today (Monday).

8 Nov 2019

Scientists identify a novel method for treating chronic pain

Watching immersive 360 videos of icy Arctic scenes helps to relieve intense burning pain and could hold hope for treating chronic pain, a small study has found.

8 Nov 2019

National effort to develop implantable bio-artificial kidney achieves key milestone

The Kidney Project, a national effort to develop an implantable bio-artificial kidney that could eliminate the need for dialysis, will announce a key milestone in a November 7, 2019 presentation at the American Society of Nephrology Kidney Week 2019 conference in Washington, DC.

7 Nov 2019

Therapy News and Research

Children with Down syndrome at greater risk of an associated form of arthritis

Effective non-surgical treatment options for urinary incontinence

Study shows how glucocorticoid hormones control sugar and fat levels over the course of 24 hours

Preclinical data on new drug combination to treat neuroblastoma published

Glutamine-blocking compound slows cancer growth, unleashes anti-tumor immune response

Study finds novel potential approach to treat type 2 diabetes

UC researcher finds new treatment option for liver transplant patients

Researchers identify new factors associated with higher mortality rates in Parkinson's patients

Investigators use the power of computation to build better targeted drug therapy

Genetic diversity impacts efficacy of cancer immunotherapy

Combination therapy shows promise for transplanting HCV-infected organs

Breakthrough research discovers new way to slow progression of diabetic kidney disease

Kibow Biotech participates in ASN Kidney Week 2019

Promega and Merck collaborate to develop MSI companion diagnostic for use with anti-PD-1 therapy

Hitachi and CLB in Lyon-France announce research collaboration to fight against cancer with AI

New stem cell technology gives new hope for high-risk leukemia patients

First device-based, non-drug therapy for treating ADHD in children

UK to be transformed into global hub for next-generation radiotherapy research

Scientists identify a novel method for treating chronic pain

National effort to develop implantable bio-artificial kidney achieves key milestone

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News